- Home
- EVGN vs SNES Comparison
EVGN vs SNES Comparison
Compare EVGN & SNES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVGN
- SNES
- Stock Information
- Founded
- EVGN 1999
- SNES 2004
- Country
- EVGN Israel
- SNES United States
- Employees
- EVGN N/A
- SNES N/A
- Industry
- EVGN Agricultural Chemicals
- SNES Agricultural Chemicals
- Sector
- EVGN Industrials
- SNES Industrials
- Exchange
- EVGN Nasdaq
- SNES Nasdaq
- Market Cap
- EVGN 7.3M
- SNES 6.7M
- IPO Year
- EVGN N/A
- SNES 2016
- Fundamental
- Price
- EVGN $1.28
- SNES $4.80
- Analyst Decision
- EVGN Strong Buy
- SNES Strong Buy
- Analyst Count
- EVGN 1
- SNES 1
- Target Price
- EVGN $3.50
- SNES $10.00
- AVG Volume (30 Days)
- EVGN 5.5M
- SNES 228.1K
- Earning Date
- EVGN 08-21-2025
- SNES 08-07-2025
- Dividend Yield
- EVGN N/A
- SNES N/A
- EPS Growth
- EVGN N/A
- SNES N/A
- EPS
- EVGN N/A
- SNES N/A
- Revenue
- EVGN $6,765,000.00
- SNES $1,927,000.00
- Revenue This Year
- EVGN N/A
- SNES $130.53
- Revenue Next Year
- EVGN $113.18
- SNES $80.00
- P/E Ratio
- EVGN N/A
- SNES N/A
- Revenue Growth
- EVGN N/A
- SNES 40.15
- 52 Week Low
- EVGN $0.95
- SNES $1.30
- 52 Week High
- EVGN $7.19
- SNES $6.48
- Technical
- Relative Strength Index (RSI)
- EVGN 47.33
- SNES 76.68
- Support Level
- EVGN $1.34
- SNES $3.56
- Resistance Level
- EVGN $1.63
- SNES $4.46
- Average True Range (ATR)
- EVGN 0.16
- SNES 0.38
- MACD
- EVGN -0.02
- SNES 0.10
- Stochastic Oscillator
- EVGN 15.56
- SNES 97.61
About EVGN Evogene Ltd
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment, followed by Industry.
About SNES SenesTech Inc.
SenesTech Inc is a United States-based biotech platform and research company engaged in developing technology for managing animal pest populations through fertility control. The company provides its solutions to the animal market, commercial markets, and food markets. It currently has two product lines of fertility control products: ContraPest and Evolve.